Table 2.
Cyathostomin faecal egg counts and percentage faecal egg count reduction at 2 weeks post-treatment with 95% confidence intervals
| Treatment group | Farm | Trial | N* | FECs pre-treatment (EPG) | FECs post-treatment (EPG) week 2 | N** | %FECR (95% CI) by AAEP method | %FECR (95% CI) Bayesian hierarchical model |
||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | Range | Mean | Range | |||||||
| Oxfendazole | A | 1 | 5 | 795 | 165–2730 | 1122 | 330–1890 | 5 | − 41 (− 195 to − 57) | 0 (0–5) |
| Abamectin | A | 1 | 5 | 774 | 315–1980 | 207 | 0–570 | 4 | 73 (60–84) | 73 (65–79) |
| Moxidectin | A | 1 | 5 | 546 | 240–930 | 0 | – | 0 | 100 | 100 (98–100) |
| Abamectin + morantel | A | 1 | 5 | 561 | 150–1290 | 0 | – | 0 | 100 | 100 (98–100) |
| Oxfendazole + pyrantel | A | 1 | 5 | 870 | 150–2235 | 159 | 15–225 | 5 | 82 (66–92) | 82 (76–86) |
| Moxidectin | B | 1 | 7 | 1530 | 75–3480 | 148 | 0–675 | 5 | 90 (70–99) | 90 (88–93) |
| Moxidectin | A | 2 | 5 | 480 | 150–630 | 0 | – | 0 | 100 | 100 (98–100) |
| Abamectin + morantel | A | 2 | 5 | 162 | 45–450 | 0 | – | 0 | 100 | 100 (94–100) |
| Moxidectin | B | 2 | 5 | 1041 | 150–1455 | 117 | 75–165 | 5 | 89 (82–94) | 89 (85–92) |
AAEP American Association of Equine Practitioners, CI confidence interval, EGP eggs per gram, FEC faecal egg count, FECR faecal egg count reduction, N* number of horses in group, N** number of horses shedding eggs within a group 2 weeks post-treatment